AR003176A1 - Una composicion farmaceutica para inhibir el crecimiento de cancer - Google Patents
Una composicion farmaceutica para inhibir el crecimiento de cancerInfo
- Publication number
- AR003176A1 AR003176A1 ARP960103861A AR10386196A AR003176A1 AR 003176 A1 AR003176 A1 AR 003176A1 AR P960103861 A ARP960103861 A AR P960103861A AR 10386196 A AR10386196 A AR 10386196A AR 003176 A1 AR003176 A1 AR 003176A1
- Authority
- AR
- Argentina
- Prior art keywords
- cancer
- pharmaceutical composition
- inhibit
- growth
- griseofulvin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US183995P | 1995-08-03 | 1995-08-03 | |
US67418196A | 1996-07-16 | 1996-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR003176A1 true AR003176A1 (es) | 1998-07-08 |
Family
ID=26669547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960103861A AR003176A1 (es) | 1995-08-03 | 1996-08-02 | Una composicion farmaceutica para inhibir el crecimiento de cancer |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0841914A2 (xx) |
JP (1) | JPH11511136A (xx) |
KR (1) | KR19990036137A (xx) |
AR (1) | AR003176A1 (xx) |
AU (1) | AU713031B2 (xx) |
BR (1) | BR9609920A (xx) |
CA (1) | CA2228503A1 (xx) |
CZ (1) | CZ30598A3 (xx) |
HU (1) | HUP9903506A3 (xx) |
IL (1) | IL123094A0 (xx) |
MX (1) | MX9800945A (xx) |
NO (1) | NO980420L (xx) |
PL (1) | PL324905A1 (xx) |
SK (1) | SK14298A3 (xx) |
TR (1) | TR199800244T2 (xx) |
WO (1) | WO1997005870A2 (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
CA2337690C (en) * | 1998-07-27 | 2013-10-01 | Texas Pharmaceuticals, Inc. | Chemically induced intracellular hyperthermia |
EP1616572B1 (en) * | 1998-11-09 | 2010-09-01 | Biogen Idec Inc. | Chimeric anti-CD20 antibody, rituxan, for use in the treatment of chronic lymphocytic leukemia |
US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
EP1407784B1 (en) * | 2001-06-25 | 2010-11-24 | Ajinomoto Co., Inc. | Antitumor agents |
EP2008652A1 (en) * | 2007-06-28 | 2008-12-31 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
EP2204367A1 (en) | 2008-12-22 | 2010-07-07 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
-
1996
- 1996-07-30 AU AU66834/96A patent/AU713031B2/en not_active Ceased
- 1996-07-30 MX MX9800945A patent/MX9800945A/es unknown
- 1996-07-30 CA CA002228503A patent/CA2228503A1/en not_active Abandoned
- 1996-07-30 PL PL96324905A patent/PL324905A1/xx unknown
- 1996-07-30 IL IL12309496A patent/IL123094A0/xx unknown
- 1996-07-30 KR KR1019980700805A patent/KR19990036137A/ko not_active Application Discontinuation
- 1996-07-30 BR BR9609920A patent/BR9609920A/pt unknown
- 1996-07-30 WO PCT/US1996/012475 patent/WO1997005870A2/en not_active Application Discontinuation
- 1996-07-30 CZ CZ98305A patent/CZ30598A3/cs unknown
- 1996-07-30 TR TR1998/00244T patent/TR199800244T2/xx unknown
- 1996-07-30 EP EP96926807A patent/EP0841914A2/en not_active Withdrawn
- 1996-07-30 SK SK142-98A patent/SK14298A3/sk unknown
- 1996-07-30 JP JP9508495A patent/JPH11511136A/ja active Pending
- 1996-07-30 HU HU9903506A patent/HUP9903506A3/hu unknown
- 1996-08-02 AR ARP960103861A patent/AR003176A1/es not_active Application Discontinuation
-
1998
- 1998-01-30 NO NO980420A patent/NO980420L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH11511136A (ja) | 1999-09-28 |
HUP9903506A2 (hu) | 2000-06-28 |
NO980420L (no) | 1998-04-03 |
EP0841914A2 (en) | 1998-05-20 |
CZ30598A3 (cs) | 1998-06-17 |
MX9800945A (es) | 1998-04-30 |
BR9609920A (pt) | 1999-07-06 |
IL123094A0 (en) | 1998-09-24 |
WO1997005870A3 (en) | 1997-04-17 |
AU6683496A (en) | 1997-03-05 |
TR199800244T2 (xx) | 1998-09-21 |
CA2228503A1 (en) | 1997-02-20 |
PL324905A1 (en) | 1998-06-22 |
AU713031B2 (en) | 1999-11-18 |
KR19990036137A (ko) | 1999-05-25 |
SK14298A3 (en) | 1998-09-09 |
HUP9903506A3 (en) | 2000-07-28 |
NO980420D0 (no) | 1998-01-30 |
WO1997005870A2 (en) | 1997-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR003176A1 (es) | Una composicion farmaceutica para inhibir el crecimiento de cancer | |
DE3767003D1 (de) | Topische antimikrobielle pharmazeutische zusammensetzung enthaltend eine silberverbindung und ein azol. | |
AU9536898A (en) | 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein | |
MY121548A (en) | Compounds and methods for the treatment of cancer | |
DK0650483T3 (da) | (3R,4R)-Delta6-tetrahydrocannabinol-7-syrer | |
FI963232A (fi) | Antimikrobisena aineena käytettävä hapotettu nitriitti | |
BR9812122A (pt) | Combinação de inibidor da tirosina quinase e castração quìmica para tratar câncer da próstata | |
AU3887797A (en) | Pentafluorobenzenesulfonamides and analogs | |
MX9308013A (es) | 4-fenil-piridonas y 4-fenil-2-fenil-2-alcoxipiridinas sustituidas, procedimiento para su preparacion y medicamentos que los contienen. | |
AR012626A1 (es) | Una composicion farmaeutica que comprende un derivado o análogo de leptina como inhibidor de la proliferacion de células de tumor y el uso de dicha composicion farmaceutica para la manufactura de medicamento para el tratamiento de tumores | |
MX9400434A (es) | Potenciamiento de temozolomida en celulas de tumores humanos. | |
ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
BR0009524A (pt) | Uso de um composto, e, composição farmacêutica ou veterinaria | |
CA2245890A1 (en) | Use of an extract of cimicifuga racemosa | |
BR9712141A (pt) | Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas. | |
AU563831B2 (en) | N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives | |
UY26678A1 (es) | El uso de composiciones a base de antibióticos de azalidos para tratar o prevenir una infección bacteriana o protozoaria en mamíferos | |
TR200101693T2 (tr) | Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi. | |
NZ509051A (en) | Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use | |
MD960168A (ro) | Metodă şi compuşi pentru tratamentul infecţiilor virale | |
UY26648A1 (es) | Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada | |
ES2031462T3 (es) | Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima. | |
ATE353639T1 (de) | In-vitro-verwendung von astaxanthin zur vorbehandlung von zellen vor uv-bestrahlung zwecks hemmung der aktivierung von nf-kb | |
UY26498A1 (es) | Pirroles sustituidos | |
AU4040195A (en) | Topical composition containing penciclovir |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |